Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Peripheral Perfusion Versus Lactate Targeted Fluid Resuscitation in Septic Shock: ANDROMEDA-SHOCK PHYSIOLOGY STUDY

NCT03762005 is registered in ClinicalTrials.gov with Pontificia Universidad Catolica de Chile as lead sponsor.

NCT NCT03762005
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03762005 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Peripheral Perfusion Versus Lactate Targeted Fluid Resuscitation in Septic Shock: ANDROMEDA-SHOCK PHYSIOLOGY STUDY
Lead sponsor
Pontificia Universidad Catolica de Chile
Phase
Not applicable
Overall status
Unknown status
Start date
June 1, 2018
Completion date
December 31, 2019
Enrollment
46 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperlactatemia, peripheral perfusion, septic shock